Central Pacific Bank - Trust Division »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Central Pacific Bank - Trust Division

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Central Pacific Bank - Trust Division from 13F filings

Historical chart of Central Pacific Bank - Trust Division investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Central Pacific Bank - Trust Division consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Central Pacific Bank - Trust Division

Quarter filed Position value Share count Share price at filing
2024-09-30 $517k 435k 1.19
2024-06-30 $259k 233k 1.11
2024-03-31 $228k 233k 0.98

More positions owned by Central Pacific Bank - Trust Division

Ishares Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
State Street ETF/USA Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
BlackRock Fund Advisors Core Total Usd (IUSB)
Ishares Core Msci Eafe (IEFA)
Invesco Capital Management Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)
Vanguard Etf/usa Vg Tl Intl Stk F (VXUS)
Meta Platforms Cl A (META)
Ishares Iboxx Inv Cp Etf (LQD)
iShares ETFs/USA Core Msci Emkt (IEMG)
Progressive Corporation (PGR)

View all positions for Central Pacific Bank - Trust Division

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1